Study 1 (NCT 00123253) This study re-randomized 207 HIV-infected patients with lipodystrophy who completed a 2 mg dose of EGRIFTA (1 mg/vial formulation) treatment in the Main Phase to receive either EGRIFTA (N=154) or placebo (N=50) for an additional 26-week duration (3:1 randomization ratio)
Un traitement adapt (oral, sublingual ou injection) sera alors prescrit selon la cause et la svrit
Mecobalamin Zusanli acupoint injection in adjuvant treatment on diabetic peripheral neuropathy of lower limb

How Its Administered Taken orally as a standard capsule or tablet Doses typically range from 2501,000 mcg per serving, often once or twice daily No mixing or refrigeration required Pros Convenient and needle-free Travel-friendly and easy to store Familiar supplement format (great for compliance) May offer limited GI tract effects if it survives digestion Cons Very low bioavailability due to breakdown in stomach acid No clinical research validating capsule efficacy May contain unverified peptide content or underdosed formulas Often marketed as dietary supplements, not research-grade peptides Best For Casual users seeking convenience or placebo-based support Individuals with mild digestive discomfort looking for a general gut health product Users who cannot access injectable or oral liquid BPC157, but still want to try the compound If considering capsules, look for third-party testing and clear labeling of dosage and peptide identity many products on the market may not contain actual BPC157

A recovery stack studied for faster tissue repair and healing Free Shipping on orders over $200 Scan the QR code on any vial to verify its batch, COA, and origin in seconds